GSK seeks injunction preventing roll-out of inhaler for asthmatics by rival over alleged trademark infringement

GlaxoSmithKline

A MAJOR pharmaceutical company is seeking an injunction preventing the roll-out by a rival of an inhaler for asthmatics over alleged infringement of its trademark.

GlaxoSmithKline (GSK) says Rowex Ltd  is preparing to put on the market a product similar in its packaging to Glaxo's "Seretide" inhaler which is the fourth highest selling pharmaceutical product in the world with more than $62 billion in global sales, including Ireland.